Company & Sponsor Intelligence
AstraZeneca
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials16
Recruiting0
Completed16
Countries7
Therapeutic footprint
alzheimersdepressionepilepsypain_neuropathyparkinsonsschizophrenia
Indexed studies
NCT01744301Acid Suppressing Drug Seizure Epidemiology Study
epilepsy · SpainCOMPLETED
epilepsy · SpainCOMPLETED
NCT01325402An Open Positron Emission Tomography Study to Assess the Effects of Varying Mass of AZD4694 on Radioligand Binding Parameters in Healthy Volunteers and Patients With Alzheimer's Disease
alzheimers · SwedenPHASE1
alzheimers · SwedenPHASE1
NCT00829088Investigation of Rate + Extent of Excretion of Radioactivity in Urine +Faeces After Oral Administration of [14C]AZD2066
pain_neuropathy · United KingdomPHASE1
pain_neuropathy · United KingdomPHASE1
NCT00689637Drug Interaction Study Between AZD3480 and Warfarin
alzheimers · SwedenPHASE1
alzheimers · SwedenPHASE1
NCT00687141Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD0328 in Elderly Healthy Subjects
alzheimers · SwedenPHASE1
alzheimers · SwedenPHASE1
NCT02040987AZD3293 Thorough QT Study in Healthy Male Volunteers
alzheimers · United StatesPHASE1
alzheimers · United StatesPHASE1
NCT03272165Single Ascending Dose Study of MEDI1341 in Healthy Volunteers
parkinsons · United StatesPHASE1
parkinsons · United StatesPHASE1
NCT02126514A Phase I, Open-Label, Single-Center Study to Assess the Absorption, Metabolism, and Excretion of [14C]-AZD3293
alzheimers · United StatesPHASE1
alzheimers · United StatesPHASE1
NCT00206102A Study of the Cataractogenic Potential of Seroquel and Risperdal in the Treatment of Participants With Schizophrenia or Schizoaffective Disorder
schizophrenia · United StatesPHASE4
schizophrenia · United StatesPHASE4
NCT00690248Depressive Symptoms in Acute Manic Episode
depression · SpainCOMPLETED
depression · SpainCOMPLETED
NCT00621647Seroquel- Agitation Associated With Dementia
alzheimers · PHASE3
alzheimers · PHASE3
NCT01202617Seroquel XR in the Long Term Treatment of Schizophrenia
schizophrenia · HungaryCOMPLETED
schizophrenia · HungaryCOMPLETED
Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →